Follow us

Follow us

All news

Total 24 Results for:
Clear all filters
  1. Healthcare

Showing 12 out of 24 results

27 April 2023

Herbert Smith Freehills advises joint sponsors on MedSci Healthcare's Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人律师为梅斯健康香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised China International Capital Corporation Hong Kong Securities Limited, and Macquarie …
8 November 2022

Herbert Smith Freehills advises CICC as the sole sponsor on LEPU ScienTech's Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人中金公司律师为乐普心泰医疗香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised China International Capital Corporation as the sole sponsor of LEPU ScienTech Medical …
10 October 2022

Herbert Smith Freehills advises sponsors on Jenscare's Hong Kong IPO 史密夫斐尔律师事务所作为保荐人律师为健世科技香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised China International Capital Corporation and Citigroup as joint sponsors of Jenscare …
19 August 2022

Herbert Smith Freehills advises Sanofi on €300 million equity investment in Innovent 史密夫斐尔律师事务所就赛诺菲对信达生物3亿欧元股权投资提供法律服务

Leading international law firm Herbert Smith Freehills has advised innovative global healthcare company Sanofi on its €300 million strategic equity …
8 July 2022

Herbert Smith Freehills advises sole sponsor on Rainmed Medical Limited's Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人律师为润迈德医疗香港上市提供法律服务

Leading international law firm Herbert Smith Freehills has advised Huatai Financial Holdings as the sole sponsor of medical device company Rainmed …
11 October 2021

Herbert Smith Freehills advises IFM on sale of Genie Solutions to Pacific Equity Partners’ owned Citadel

Herbert Smith Freehills has advised IFM Investors’ private equity arm on the sale of its majority owned medical practice management software business, …
20 August 2021

Herbert Smith Freehills advises on Shanghai HeartCare Medical's HK$1.13 billion Hong Kong IPO 史密夫斐尔律师事务所为心玮医疗11.3亿港元IPO提供法律服务

Leading global law firm Herbert Smith Freehills has advised neuro-interventional medical device manufacturer Shanghai HeartCare Medial Technology …
18 June 2021

Herbert Smith Freehills advises sponsors on CARsgen Therapeutics’ HK$3.1 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为科济药业31亿港元IPO提供法律服务

Leading global law firm Herbert Smith Freehills has advised Goldman Sachs and UBS as joint sponsors of biopharmaceutical company CARsgen Therapeutics …
9 April 2021

Herbert Smith Freehills advises Rosemary Health on Series Seed-2 capital raise

Herbert Smith Freehills’ Venture Capital team has advised Rosemary Health on its Series Seed-2 capital raise.Rosemary Health is a telehealth platform …
24 February 2021

Australian IPOs defy early expectations to achieve record end to 2020

The outlook for Australian IPO activity in 2021 is promising following a spate of listings on the ASX in the second half of 2020, according to a new …
7 December 2020

Hiswara Bunjamin & Tandjung advises PT Omni Healthcare on sale of controlling stake in PT Sarana Meditama Metropolitan Tbk

Leading Indonesian law firm Hiswara Bunjamin & Tandjung (HBT) has advised Indonesian hospital group PT Omni Healthcare on the sale of its controlling …
20 November 2020

Herbert Smith Freehills advises sponsors on Antengene’s HK$2.6 billion Hong Kong IPO / 史密夫斐尔律师事务所作为联席保荐人境外律师为德琪医药26亿港元IPO提供法律服务

Leading global law firm Herbert Smith Freehills has advised Goldman Sachs and JP Morgan as joint sponsors of biopharmaceutical company Antengene …